Tolerability of ivermectin in gnathostomiasis

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 3, 2005, Pages 644-649

  Bussaratid, Valai ^a   Krudsood, Srivicha ^a   Silachamroon, Udomsak ^a   Looareesuwan, Sornchai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24944488046     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anantaphruti M, Nuamtanong S, Waikagul J. Effect of ivermectin on experimental gnathostomiasis in rabbits. Trop Med Parasitol 1992; 43: 65-7.
2. Aziz MA, Diallo S, Diop IM, Lariviere M, Porta M. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 1982; 2: 171-3.
3. Bockarie MJ, Alexander ND, Hyun P, et al. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Lancet 1998; 351: 162-8.
4. Coulard JP, Lariviere M, Gervais MC, et al. Treatment of human onchocerciasis with ivermectin. Bull Soc Pathol Exot Filiales 1983; 76: 681-8 (In French).
5. Coutinho A, Dreyer G, Mediros Z, et al. Ivermectin treatment of bancroftian filariasis in Recife, Brazil. Am J Trop Med Hyg 1994; 50: 339-48.
6. Darty A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: resuits of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994; 88: 344-5.
7. De Sole G, Remme J, Awadzi K, et al. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull WHO 1989; 67: 707-19.
8. Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabei hyperinfestation. Int J Infect Dis 1998; 2: 152-4.
9. Inkatanuwat S, Suntharasamai P, Vutikes S, Riganti M. Changes of liver functions after albendazole treatment in human gnathostorniasis. J Med Assoc Thai 1998; 81: 735-40.
10. Kombila M, Duong T, Ferrer A, et al. Short-and long-term action of multiple doses of ivermectin on loiasis microfilaremia. Am J Trop Med Hyg 1998; 58: 458-60.
11. Kraivichian P, Kulkumthorn M, Yingyourd P, Akarabovorn P, Paireepai CC. Albendazole for the treatment of human gnathostomiasis. Trans R Soc Trop Med Hyg 1992; 86: 418-21.
12. Kumaraswami V, Ottesen EA, Vijayasekaran V, et al. Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions. J Am Med Assoc 1988; 259: 3150-3.
13. Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med 1995; 333: 26-30.
14. Merck & Co, Inc. Merck Annual Report. 1995: 5-20.
15. Njoo FL, Belling GA, Oosting J, Vetter JC, Stilma JS, Kijlstra A. Concurrent parasitic infections in onchocerciasis and the occurrence of adverse reactions after ivermectin treatment. Am J Trop Med Hyg 1993; 48: 652-7.
16. Ottesen EA, Campbell WC. Ivermectin in human medicine. J Antimicrob Chemother 1994; 34: 195-203.
17. Pacque MC, Dukuly Z, Greene BM, et al. Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions. Bull WHO 1989; 67: 721-30.
18. st ed. Bangkok: Bangkok Medical Media Publishing; 1996: 172-4 (In Thai).
19. Shikiya K, Kinjo N, Uehara T, et al. Efficacy of ivermectin against Strongyloides stercoralis in humans. Intern Med 1992; 31: 310-2.
20. nd ed. London: Oxford University Press; 1987: 5.558-5.561.
21. Suntharasamai P, Riganti M, Chittamas S, Desakorn V. Albendazole stimulates outward migration of Gnathostoma spinigerum to the dermis in man. Southeast Asian J Trop Med Public Health 1992; 23: 716-22.